Baird raised the firm’s price target on Bright Horizons (BFAM) to $140 from $131 and keeps a Neutral rating on the shares. The firm said they reportedmixed results but the upside was driven by continued excellent Back-Up Care. However, Full Service revenue versus same-center enrollment growth slowing, while 2024 Full Service revenue guidance narrowed to the lower half of the prior range.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter